Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7B
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
Key Takeaways: Payward will acquire Bitnomial to add a fully licensed U.S. crypto derivatives platform to its business. Bitnomial gives…
Crypto exchange Kraken’s parent company has agreed to acquire digital asset derivatives platform Bitnomial for up to $550 million, in…
EToro (ETOR) has agreed to acquire crypto wallet provider Zengo as it brings self-custody tools into its trading platform in…
Sony Group Corporation (NYSE:SONY) is one of the 7 Best Strong Buy Asian Stocks to Invest In. On April 3,…
TVS Venu Group has signed binding agreements to take over Prudential Financials’ full holding in PGIM India Asset Management and…
Canada-based Mayfair Gold has signed a definitive agreement to acquire three properties owned by Plato Gold in exchange for C$2.5m…
Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S.,…
Gilead Sciences, Inc. (NASDAQ:GILD) is included among the Dividend Stock Portfolio for Income: 15 Stocks to Invest In. Gilead to…
Novartis AG reached an agreement to pay as much as $2 billion to acquire biotech firm Excellergy Inc. www.bloomberg.com #Novartis…